MiNA Therapeutics procures $30m Series A
MiNA Therapeutics, a provider of RNA activation therapeutics, has raised $30 million in Series A funding.
MiNA Therapeutics, a provider of RNA activation therapeutics, has raised $30 million in Series A funding.
Copyright PEI Media
Not for publication, email or dissemination